4-Bromo-3-fluoroanisole

We are 4-Bromo-3-fluoroanisole CAS:408-50-4 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:4-Bromo-3-fluoroanisole
CAS.NO:408-50-4
Synonyms:4-Bromo-3-fluoroanisole
 
Physical and Chemical Properties:
Molecular Formula C7H6BrFO
Molecular Weight 205.02400
 
Specification:
Appearance:Colorless transpatent liquid
Assay:≥98.0%
 
Packing:10 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Organic synthesis.

4-Bromo-3-fluoroanisole


Related News: In terms of business, the industrial business increased by 7.97% year-on-year, while the revenue from the trading business shrank to a certain extent. The growth rate of industrial business was significantly slower than 24% in the first half of the year, showing that the growth rate of industrial business was lower in the third quarter, which was also the main reason for the decline in the company’s operating income in the third quarter. The company’s industrial business is mainly pesticide intermediates, accounting for about 85%. The scale of the pesticide intermediate business is large and the base is high, which is putting pressure on growth.2-Bromo-2-methylpropane From the perspective of the overall life cycle of generic drugs from R & D to sales, with the expiration of patents, the business model for the production and marketing of generic pharmaceutical raw materials has changed, demand has increased, business potential has been realized quickly, and gross profit margins have shown a downward trend.Diethoxymethylsilane As part of the agreement, ICIG will enter into a 5-year supply contract to provide Genzyme with materials needed for the production of eliglustat tartrate, an investigational treatment for Gaucher disease Type 1 that is currently in Phase III clinical trials.4-[2-(1-Pipiridine)ethoxybenzoic acid hydrochloride CAS:84449-80-9 As part of the agreement, ICIG will enter into a 5-year supply contract to provide Genzyme with materials needed for the production of eliglustat tartrate, an investigational treatment for Gaucher disease Type 1 that is currently in Phase III clinical trials.It does not require a production license for the drug substance, and can be produced in an ordinary chemical plant. As long as it reaches a certain level, it can be used for the synthesis of the drug substance.

Related Products
Product Name
4-Bromo-3-methylbenzoic acid View Details
2,6-dichlorobenzenethiol View Details
2,2′-Dichlorodiethyl ether View Details
2-Chloro-5-fluoro-3-methylpyridine manufacturer Vinylmethyldimethoxysilane manufacturer 4,5-Difluoro-2-nitrobenzoic acid manufacturer tert-Butyl 3-oxoazetidine-1-carboxylate manufacturer 4-Cyanobenzyl bromide manufacturer